Anticorps Monoclonal anti-Phospho-P53 (Ser15)
Phospho-P53 (Ser15) Monoclonal Antibody for FC, IF, WB, ELISA
Hôte / Isotype
Mouse / IgG1
Réactivité testée
Humain et plus (2)
Applications
WB, IF, FC, ELISA
Conjugaison
Non conjugué
CloneNo.
1H6G1
N° de cat : 67826-1-Ig
Synonymes
Galerie de données de validation
Applications testées
Résultats positifs en WB | cellules HT-29 traitées à la calyculine A, cellules HEK-293T, cellules HEK-293T, cellules HT-29 |
Résultats positifs en IF | cellules HT-29 traitées à l'étoposide, |
Résultats positifs en cytométrie | UV treated HT-29 cells, |
Dilution recommandée
Application | Dilution |
---|---|
Western Blot (WB) | WB : 1:1000-1:6000 |
Immunofluorescence (IF) | IF : 1:200-1:800 |
Flow Cytometry (FC) | FC : 0.13 ug per 10^6 cells in a 100 µl suspension |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, check data in validation data gallery |
Applications publiées
WB | See 10 publications below |
IF | See 1 publications below |
Informations sur le produit
67826-1-Ig cible Phospho-P53 (Ser15) dans les applications de WB, IF, FC, ELISA et montre une réactivité avec des échantillons Humain
Réactivité | Humain |
Réactivité citée | rat, Humain, souris |
Hôte / Isotype | Mouse / IgG1 |
Clonalité | Monoclonal |
Type | Anticorps |
Immunogène | Peptide |
Nom complet | tumor protein p53 |
Masse moléculaire calculée | 44 kDa |
Poids moléculaire observé | 53 kDa |
Numéro d’acquisition GenBank | BC003596 |
Symbole du gène | TP53 |
Identification du gène (NCBI) | 7157 |
Conjugaison | Non conjugué |
Forme | Liquide |
Méthode de purification | Purification par protéine A |
Tampon de stockage | PBS avec azoture de sodium à 0,02 % et glycérol à 50 % pH 7,3 |
Conditions de stockage | Stocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA. |
Informations générales
TP53, also known as P53 and NY-CO-13, belongs to the p53 family and has 9 isoforms. In SDS-Page, the observed molecular weight is about 53 kDa. TP53 acts as a tumor suppressor in many tumor types, including growth arrest or apoptosis depending on the physiological circumstances and cell types. It is involved in cell cycle regulation as a trans-activator that acts to negatively regulate cell division by controlling a set of genes required for this process. TP53 Localizes in the nucleus in most cells but found in the cytoplasm in some cells. (PMID: 26166714; PMID: 25225161)
Protocole
Product Specific Protocols | |
---|---|
WB protocol for Phospho-P53 (Ser15) antibody 67826-1-Ig | Download protocol |
IF protocol for Phospho-P53 (Ser15) antibody 67826-1-Ig | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |
Publications
Species | Application | Title |
---|---|---|
J Virol Hepatitis B doubly spliced protein (HBDSP) promotes hepatocellular carcinoma cell apoptosis via ETS1/GATA2/YY1-mediated p53 transcription | ||
Front Pharmacol A New Chalcone Derivative C49 Reverses Doxorubicin Resistance in MCF-7/DOX Cells by Inhibiting P-Glycoprotein Expression. | ||
Toxicol Lett The mechanism of rh-endostatin-induced cardiotoxicity and its protection by dihydromyricetin[in vivo/in vitro, C57BL/6 mice, AC16 and hiPSC-CMs] | ||
World Neurosurg N-acetylserotonin protects rat nucleus pulposus cells against oxidative stress injury by activating the PI3K/AKT signaling pathway | ||
Front Pharmacol Simultaneous suppression of PKM2 and PHGDH elicits synergistic anti-cancer effect in NSCLC | ||
Discov Oncol Anticancer efficacy of hirsuteine against colorectal cancer by opposite modulation of wild-type and mutant p53 |